title: [Malignant mediastinal lymph node tumors with unknown primary cancers].
abstract: OBJECTIVE
  Malignant mediastinal lymph nodes with unknown primary tumor is a rare occurrence. The purpose of this study is to specify some characteristics of the patients presenting with this disease and to define an adequate therapeutic approach.
  
  
  METHODS
  Between 1985 and 1997, we have operated on 54 patients with isolated non-small cell malignancy to mediastinal lymph nodes. Forty-nine patients underwent surgical biopsy of the mediastinal mass, generally followed by radiation therapy and/or chemotherapy. A mediastinal lymph node resection was performed in 5 patients.
  
  
  RESULTS
  Five patients were lost to follow-up (9.3%). The 5-year survival rate and the median survival were 12.4 +/- 5% and 7 months respectively. Four of the 7 patients who were still alive after follow-ups ranging from 10 to 68 months had undergone a lymph node resection. During the follow-up, a primary tumor was discovered in only 5 patients (11.4%).
  
  
  CONCLUSIONS
  Patients with isolated malignant lymph nodes of the mediastinum have a poor prognosis. In order to improve their survival, we recommend a more aggressive therapeutic approach comprising a chemotherapy and a mediastinal lymph node resection, associated in some cases with a lung resection. Radiation therapy of the mediastinum can be administered, principally in case of incomplete resection.
authors.affiliation: Service de Chirurgie Thoracique, Hôpital Européen Georges Pompidou, Paris, France.
authors.forename: E
authors.initials: E
authors.lastname: Faure
authors.forename: M
authors.initials: M
authors.lastname: Riquet
authors.forename: P M
authors.initials: PM
authors.lastname: Lombe-Weta
authors.forename: J P
authors.initials: JP
authors.lastname: Hübsch
authors.forename: F
authors.initials: F
authors.lastname: Carnot
mesh_terms: D000206:Actuarial Analysis; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001706:Biopsy; D018288:Carcinoma, Small Cell / Q000401:mortality / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D017024:Chemotherapy, Adjuvant; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis / Q000473:pathology*; D008297:Male; D008479:Mediastinal Neoplasms / Q000401:mortality / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D008875:Middle Aged; D009382:Neoplasms, Unknown Primary / Q000473:pathology*; D011013:Pneumonectomy; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D016019:Survival Analysis
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Adénopathies tumorales du médiastin sans cancer primitif.